Project Grant HT94252310934
Award Date
9/1/23
Completion Date
8/31/26
Dollars Obligated
$733K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
The Defense Health Agency awarded a $4,319,388 Project Grant to the University of Melbourne to fund research aimed at "TARGETING SENESCENT CELLS TO IMPROVE OUTCOMES FOR BREAST CANCER PATIENTS" over the period from September 1, 2024 to August 31, 2028. This grant is provided under the Military Medical Research and Development Program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
The University of Melbourne was awarded a $768,263 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research on developing a novel inhibitor of ribosome biogenesis with antitumor activity in preclinical models of prostate cancer. The goal of the Military Medical Research and Development program is to transform military and public health through innovative medical research solutions. This award will...
The Department of the Army Medical Command awarded $608,341 to Monash University under the Military Medical Research and Development federal grant program (CFDA 12.420) from September 15, 2022 through September 14, 2025. The project grant funding will support Monash University's research efforts to elucidate and suppress cells of origin of cutaneous melanoma. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
The University of Melbourne was awarded a $591,778 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Harnessing the Immune Response in Exceptionally Long-Term Survivors to Develop Novel Therapeutics." The project will run from May 1, 2024 to April 30, 2027. The University of Melbourne has a history of conducting federal research and consulting work in areas such as...
This federal Project Grant award of $563,707.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the University of Queensland in Australia to predict early-stage melanoma at high risk of recurrence through multiomics profiling. The grant, awarded on September 1, 2025, aims to transform healthcare for military service members, veterans, and the public through innovative biomedical research. The University of Queensland, a...
The University of Queensland in Australia was awarded a $1,488,596 Project Grant from the Department of the Army Medical Command to support melanoma research from September 2022 through September 2025. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine and other health issues. Under this award, The University of Queensland...
The University of Melbourne was awarded a $369,855.64 Project Grant from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) to conduct research on "Piecing the Puzzle Together: Unraveling the Genomic Landscape of Low-Grade Serous Ovarian Carcinoma (LGSOC) to Guide Novel Therapeutic Strategies." This 2-year grant, running from Sep 1, 2023 to Aug 31, 2025, will support the university's efforts to advance the understanding of low-grade...
The University of Melbourne received a $1,109,929 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a neurotrophin therapy for clinical translation. The grant, awarded on September 1, 2024, will support research aimed at improving health outcomes for military service members, veterans, and the broader public by advancing innovative treatments for neurological disorders. The three-year project will...
The University of Melbourne was awarded an $854,195 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will support integrative molecular characterization and biomarker validation research in metastatic hormone-sensitive prostate cancer from September 2021 through August 2025. Through this funding, the University of Melbourne will conduct basic, applied, and advanced biomedical research to investigate medical...
The Defense Health Agency awarded a $744,997 Project Grant to the University of Queensland in Australia under the Military Medical Research and Development program (CFDA 12.420). This grant, titled "DISCOVERING THERAPEUTIC VULNERABILITIES OF CIRCULATING MELANOMA CLUSTERS," provides funding for the university to conduct cutting-edge biomedical research on melanoma from June 1, 2024 through May 31, 2027. The University of Queensland, a leading research institution in Australia, has an...